PVALB and Down syndrome: Researchers observed decreased parvalbumin levels and changes in the expression of several genes identified as potential autism risk factors in humans, confirming that this mouse model could be suitable for studying ASD related to CTNNB1 syndrome, but lacking motor deficits as seen in CTNNB1 syndrome patients.